Steven Gillis's Insider Trades & SAST Disclosures
Steven Gillis's most recent trade in VBI Vaccines Inc. was a trade of 52,500 Option (Right to Buy Common Shares) done . Disclosure was reported to the exchange on July 27, 2023.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Steven Gillis.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| VBI Vaccines Inc. | Steven Gillis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2023 | 52,500 | 52,500 | - | - | Option (Right to Buy Common Shares) | |
| VBI Vaccines Inc. | Steven Gillis | Director | Purchase of securities on an exchange or from another person at price $ 1.65 per share. | 10 Jul 2023 | 609,090 | 1,043,292 (0%) | 0% | 1.7 | 1,004,999 | Common Shares, no par value per share |
| VBI Vaccines Inc. | Steven Gillis | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 10 Jul 2023 | 609,090 | 609,090 | - | - | Warrant (right to buy) | |
| Q32 Bio Inc. | Steven Gillis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 23,000 | 23,000 | - | - | Option (Right to Buy) | |
| VBI Vaccines Inc. | Steven Gillis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 75,000 | 75,000 | - | - | Option (Right to Buy Common Shares) | |
| Q32 Bio Inc. | Steven Gillis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 18,000 | 18,000 | - | - | Option (Right to Buy) | |
| VBI Vaccines Inc. | Steven Gillis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 100,000 | 100,000 | - | - | Option (Right to Buy Common Shares) | |
| Q32 Bio Inc. | Steven Gillis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 18,000 | 18,000 | - | - | Option (Right to Buy) | |
| VBI Vaccines Inc. | Steven Gillis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 100,000 | 100,000 | - | - | Option (Right to Buy Common Shares) | |
| Pulmatrix Inc | Steven Gillis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Aug 2020 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Steven Gillis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2020 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Steven Gillis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Aug 2020 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Steven Gillis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2020 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Steven Gillis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Aug 2020 | 12,400 | 0 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Steven Gillis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2020 | 12,400 | 12,400 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Steven Gillis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Aug 2020 | 10,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Steven Gillis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2020 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Steven Gillis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Aug 2020 | 1,771 | 0 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Steven Gillis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2020 | 1,771 | 1,771 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Steven Gillis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Aug 2020 | 880 | 0 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Steven Gillis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2020 | 880 | 880 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Steven Gillis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Aug 2020 | 440 | 0 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Steven Gillis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2020 | 440 | 440 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Steven Gillis | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Aug 2020 | 111 | 0 | - | - | Stock Option (Right to Buy) | |
| Pulmatrix Inc | Steven Gillis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Aug 2020 | 111 | 111 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Steven Gillis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 18,000 | 18,000 | - | - | Option (Right to Buy) | |
| Pulmatrix Inc | Steven Gillis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2020 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges